2012
DOI: 10.1134/s0006297912090106
|View full text |Cite
|
Sign up to set email alerts
|

Mild uncoupling of respiration and phosphorylation as a mechanism providing nephro- and neuroprotective effects of penetrating cations of the SkQ family

Abstract: It is generally accepted that mitochondrial production of reactive oxygen species is nonlinearly related to the value of the mitochondrial membrane potential with significant increment at values exceeding 150 mV. Due to this, high values of the membrane potential are highly dangerous, specifically under pathological conditions associated with oxidative stress. Mild uncoupling of oxidative phosphorylation is an approach to preventing hyperpolarization of the mitochondrial membrane. We confirmed data obtained ea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
34
0
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(36 citation statements)
references
References 54 publications
1
34
0
1
Order By: Relevance
“…If a minor decline in the ΔΨm could lead to a significant decrease in harmful levels of ROS production [65], it is reasonable to hypothesize that the optimal values of ΔΨm, might be achieved by application of “mild uncouplers” which lower ΔΨm to a level still allowing both production of required amounts of ATP, and also of lower ROS levels that would be relatively harmless to the cells [72]. Consequently, under specific cases of poorly regulated ΔΨm and ROS elevations “mild uncouplers” could potentially have beneficial properties in limiting the ravages of a number of diseases, including those associated with aging [73], obesity [74,75] and pathologies accompanied by oxidative stress, such as stroke and heart attack [7678]. Therefore, an extensive search has been initiated among the compounds with various chemical structures for new drugs which could potentially be tested therapeutically as “mild uncouplers” of oxidative phosphorylation [7984].…”
Section: Optimal Values Of δψMmentioning
confidence: 99%
“…If a minor decline in the ΔΨm could lead to a significant decrease in harmful levels of ROS production [65], it is reasonable to hypothesize that the optimal values of ΔΨm, might be achieved by application of “mild uncouplers” which lower ΔΨm to a level still allowing both production of required amounts of ATP, and also of lower ROS levels that would be relatively harmless to the cells [72]. Consequently, under specific cases of poorly regulated ΔΨm and ROS elevations “mild uncouplers” could potentially have beneficial properties in limiting the ravages of a number of diseases, including those associated with aging [73], obesity [74,75] and pathologies accompanied by oxidative stress, such as stroke and heart attack [7678]. Therefore, an extensive search has been initiated among the compounds with various chemical structures for new drugs which could potentially be tested therapeutically as “mild uncouplers” of oxidative phosphorylation [7984].…”
Section: Optimal Values Of δψMmentioning
confidence: 99%
“…Mitochondria-targeted antioxidants of the SkQ group such as plastoquinonyl-decyl-triphenylphosphonium (SkQ1) and plastoquinonyl decylrhodamine 19 (SkQR1) are positively charged compounds that prevent IRI-induced AKI (Plotnikov et al 2012) and ameliorate gentamicin-induced damage of rat kidney (Jankauskas et al 2012). Likewise, specific mitochondrially targeted heme oxygenase (HO)-1 protects against hypoxia-dependent renal epithelial cell death and loss of mitochondrial membrane potential (Bolisetty et al 2013).…”
Section: Renal Mitochondrial Targetingmentioning
confidence: 99%
“…In the current study, we used SkQ1 antioxidant, based on the plastoquinone moiety linked to dodecyltriphenylphosphonium cation that targets SkQ1 to mitochondria [26]. SkQ1 and its analogs are efficient in the prevention of some age-associated pathologies, and they have therapeutic effects in animal models of diseases associated with inflammatory response (heart, brain, and kidney ischemic injury [27, 28], pyelonephritis [29], eye diseases [30, 31], sarcopenia [32], and dermal wound healing [33]). SkQ1 delays the development of various markers of aging and prolongs the lifespan of various animals [20, 22, 34, 35].…”
Section: Introductionmentioning
confidence: 99%